abstract |
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) and Formula (II) as follows: Formula (I) wherein Y, R 1 , G, and Q are defined herein; and Formula (II) wherein R 11 , R 21 , R 41 , R B1 and G 1 , are defined herein. |